Home > Drug List > Neratinib > News of Neratinib

News of Neratinib

Neratinib was first approved for marketing by the U.S. Food and Drug Administration (FDA) in 2017, with the latest revision in June 2021.

Neratinib

Neratinib

Indications： It is indicated for the treatment of early-stage and advanced-stage HER2-positive breast cancer, and can be used as a monotherapy for adjuvant treatment or in combination with capecitabine for metasta

Scan code
Whatsapp

Medicine-related columns

Recommended Articles

Related Articles

There is no data under this category！
Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Hospital Departments
Latest Articles
Medicine Updates

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Product

Product

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved

whatsapp